Stacie B Dusetzina1, Benyam Muluneh1, Nancy L Keating1, Haiden A Huskamp1. 1. From the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Comprehensive Cancer Center, Nashville (S.B.D.); the University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Chapel Hill (B.M.); and the Department of Health Care Policy, Harvard Medical School (N.L.K., H.A.H.), and the Division of General Internal Medicine, Brigham and Women's Hospital (N.L.K.) - both in Boston.
Authors: Nancy L Keating; Gabriel A Brooks; Mary Beth Landrum; Pang-Hsiang Liu; Robert Wolf; Lauren E Riedel; Nirav S Kapadia; Shalini Jhatakia; Amanda Tripp; Carol Simon; Van Doren Hsu; Colleen M Kummet; Andrea Hassol Journal: J Natl Cancer Inst Date: 2022-06-13 Impact factor: 11.816